← Leaderboards
Gemma Casadesus
Case Western Reserve University
$6,853,515
Attributed
$6,853,515
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.4M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,853,515 · 7
By mechanism
RF1$4,189,047 · 2
R01$1,152,866 · 1
R21$1,017,797 · 2
R15$444,238 · 1
R13$49,567 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposEventPathologyBrainNeuronsSignal TransductionLinkReceptorAnimalsRodentImpaired CognitionAge RelatedIn VitroPreventCognitionCognitiveHormonesAffectBaseAgingIncidencePathogenesisAmyloid Beta-ProteinCognitive Function
Grant awards (14)
Evaluation of the neuroimmune mechanisms influencing therapeutic targetingpotential of the LH/CG receptor in the menopausal and AD brain$2,329,970
RF1 · FY2025 · AG · contact PI
International Research Conference In Neurodegenerative Diseases 2025$49,567
R13 · FY2025 · AG · contact PI
Evaluation of Chorionic Gonadotropin as a Treatment for Sepsis-induced Neuroinflammation and Cognitive Dysfunction in the Aged Brain$419,375
R21 · FY2024 · AG · contact PI
Characterization of transcriptome changes in diet-induced progression to METS/T2D to identify earliest and sex-specific neurodegenerative foci for AD development$186,969
R21 · FY2020 · AG · contact PI
Characterization of transcriptome changes in diet-induced progression to METS/T2D to identify earliest and sex-specific neurodegenerative foci for AD development$186,969
R21 · FY2020 · AG · contact PI
Characterization of transcriptome changes in diet-induced progression to METS/T2D to identify earliest and sex-specific neurodegenerative foci for AD development$224,484
R21 · FY2019 · AG · contact PI
Mechanisms of Gonadotropin Action on Cognition and Neuronal Remodeling in Aging and Alzheimer's Disease$1,052,364
RF1 · FY2017 · AG · contact PI
Mechanisms of Gonadotropin Action on Cognition and Neuronal Remodeling in Aging and Alzheimer's Disease$806,713
RF1 · FY2017 · AG · contact PI
Mechanisms of Metabolic Hormone Amylin Action on Alzheimer's Disease Pathogenesis$444,238
R15 · FY2016 · AG · contact PI
Gonadotropin in cognition and Alzheimer's disease: Therapeutic Implications$259,902
R01 · FY2012 · AG · contact PI
Gonadotropin involvement in cognition and Alzheimer's disease: Therapeutic Implications$26,866
R01 · FY2012 · AG · contact PI
Gonadotropin involvement in cognition and Alzheimer's disease: Therapeutic Implic$286,768
R01 · FY2010 · AG · contact PI
Gonadotropin involvement in cognition and Alzheimer's disease: Therapeutic Implic$289,665
R01 · FY2009 · AG · contact PI
Gonadotropin involvement in cognition and Alzheimer's disease: Therapeutic Implic$289,665
R01 · FY2008 · AG · contact PI